论文信息 - BYL719, a new α‐specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma - 字舞流文

BYL719, a new α‐specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma

D. Heymann | B. Ory | F. Blanchard | F. Redini | S. Battaglia | F. Lamoureux | C. Charrier | Rachel Lanel | F. Lézot | B. Gobin | Marc Baud' Huin